Regulation of dendritic cell function and cell-based therapy in chronic hepatitis C virus infection
慢性丙型肝炎病毒感染中树突状细胞功能的调节和细胞治疗
基本信息
- 批准号:15109006
- 负责人:
- 金额:$ 72.13万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (S)
- 财政年份:2003
- 资助国家:日本
- 起止时间:2003 至 2007
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Sequential activation of innate and adaptive immune response is crucial for virus elimination. Dendritic cells (DCs) sense virus infection via toll-like receptors (TLR) or retinoic acid inducible gene-I (RIG-I), resulting in the secretion of type-I interferons (IFN) and inflammatory cytokines. Blood DC consist of two subsets; myeloid DC (MDC) and plasmacytoid DC (PDC). In chronic hepatitis C patients, both of these DC subsets decreased compared to healthy subjects. Furthermore, MDC and PDC are functionally impaired in HCV-infected patients in the ability to stimulate T cell proliferation as well as cytokine secretion. In MDC from HCV-infected patients, regardless of higher expression of TLR2, TLR4 and RIG-I compared to the controls, the levels of TLR/RIG-I-mediated IFN-β, TNF-α or IL-12p70 induction are lower than those in uninfected donors. These results suggest that the signal transduction in the downstream of TLR/RIG-I in DC is profoundly impaired in HCV infection. In order to searc … More h for the mechanisms of above-mentioned DC malfunction in HCV infection, we inoculated pseudo-HCV particles, covered by chimeric HCV E1/E2 protein, to MDC or PDC recovered from healthy donors. Pseudo-HCV enters only MDC but not PDC, suggesting that HCV aims to infect myeloid subsets. However, unanswered question still remains for the mechanisms of HCV-induced PDC dysfunction. Cumulative reports have been published for pervasive impairment in adaptive immune system in HCV infection, such as virus-specific CD4^+ or CD8^+ T cells. Naturally occurring regulatory T cells (Tregs) are specialized T cell subsets that are capable of suppressing auto-reactive T cells. In order to clarify the roles of Treg in chronic HCV infection, we compared the frequency and function of Tregs between the patients and uninfected donors. Peripheral Tregs in chronic HCV infection is greater in frequency and in suppressive ability than those in healthy counterparts, much more in patients with persistently normal ALT levels compared to those with active hepatitis. These results imply that the abundance of Treg is beneficial for the maintenance of low-grade liver inflammation, possibly by suppressing inflammatory Th1 cells. In conclusion, active and reciprocal interactions among innate and adaptive immune cells, which are orchestrated by DC, are critical in shaping immuno-pathogenesis of HCV infection. Less
先天性和适应性免疫反应的相继激活对于消除病毒至关重要。树突状细胞(DC)通过Toll样受体(TLR)或视黄酸诱导基因-I(RIG-I)感知病毒感染,从而分泌I型干扰素(IFN)和炎症细胞因子。血液 DC 由两个子集组成;髓样 DC (MDC) 和浆细胞样 DC (PDC)。在慢性丙型肝炎患者中,与健康受试者相比,这两个 DC 亚群均有所下降。此外,HCV 感染患者的 MDC 和 PDC 刺激 T 细胞增殖和细胞因子分泌的能力受到功能损害。在 HCV 感染患者的 MDC 中,尽管与对照组相比 TLR2、TLR4 和 RIG-I 表达较高,但 TLR/RIG-I 介导的 IFN-β、TNF-α 或 IL-12p70 诱导水平低于未感染供者。这些结果表明,在HCV感染中,DC中TLR/RIG-I下游的信号转导受到严重损害。为了探究HCV感染中上述DC故障的机制,我们将嵌合HCV E1/E2蛋白覆盖的假HCV颗粒接种到从健康供体中回收的MDC或PDC中。假性HCV仅进入MDC而不进入PDC,这表明HCV旨在感染骨髓亚群。然而,HCV 引起的 PDC 功能障碍的机制仍然存在悬而未决的问题。已发表关于 HCV 感染中适应性免疫系统普遍受损的累积报告,例如病毒特异性 CD4^+ 或 CD8^+ T 细胞。天然存在的调节性 T 细胞 (Treg) 是一种特殊的 T 细胞亚群,能够抑制自身反应性 T 细胞。为了阐明Treg在慢性HCV感染中的作用,我们比较了患者和未感染供者之间Treg的频率和功能。慢性 HCV 感染者的外周 Tregs 的频率和抑制能力均高于健康人群,且与活动性肝炎患者相比,ALT 水平持续正常的患者的外周 Tregs 水平更高。这些结果表明,丰富的 Treg 有利于维持低度肝脏炎症,可能是通过抑制炎症 Th1 细胞来实现的。总之,由 DC 协调的先天性免疫细胞和适应性免疫细胞之间的积极和相互的相互作用对于形成 HCV 感染的免疫发病机制至关重要。较少的
项目成果
期刊论文数量(34)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Dendritic cells and regulatory T cells as decision markers for the duration of pegylated interferon-α and ribavirin therapy in chronic hepatitis C patients.
树突状细胞和调节性 T 细胞作为慢性丙型肝炎患者聚乙二醇化干扰素-α 和利巴韦林治疗持续时间的决策标记。
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Kanto T;Itose I;et. al.
- 通讯作者:et. al.
Hepatocyte-specific disruption of Bcl-xL leads to continuous hepatocyte apoptosis and liver fibrotic responses
- DOI:10.1053/j.gastro.2004.07.019
- 发表时间:2004-10-01
- 期刊:
- 影响因子:29.4
- 作者:Takehara, T;Tatsumi, T;Hayashi, N
- 通讯作者:Hayashi, N
Jinushi M, Takehara T, et al.: "Autocrine/paracrine IL-15 that is required for type I IFN-mediated dendritic cell expression of MHC class I-related chain A and B is impaired in hepatitis C virus infection."Journal of Immunology. 171(10). 5423-5429 (2003)
Jinushi M、Takehara T 等人:“I 型 IFN 介导的 MHC I 类相关链 A 和 B 的树突状细胞表达所需的自分泌/旁分泌 IL-15 在丙型肝炎病毒感染中受损。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Hosui A, Ohkawa K, et al.: "Hepatitis C virus core protein differentially regulates the JAK-STAT signaling pathway under interleukin-6 and interferon-γ stimuli"Journal of Biological Chemistry. 278(31). 28562-28571 (2003)
Hosui A、Ohkawa K 等人:“丙型肝炎病毒核心蛋白在白介素 6 和干扰素 γ 刺激下差异调节 JAK-STAT 信号通路”《生物化学杂志》278(31) (2003)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas
- DOI:10.1016/j.jhep.2005.05.026
- 发表时间:2005-12-01
- 期刊:
- 影响因子:25.7
- 作者:Jinushi, M;Takehara, T;Hayashi, N
- 通讯作者:Hayashi, N
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HAYASHI Norio其他文献
HAYASHI Norio的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HAYASHI Norio', 18)}}的其他基金
System identification of physiological-psychological horticultural activity effect system using hands palm
手掌生理心理园艺活动效果系统识别
- 批准号:
20688011 - 财政年份:2008
- 资助金额:
$ 72.13万 - 项目类别:
Grant-in-Aid for Young Scientists (A)
Epithelial transformation by stroma transplant in urogenital organs
泌尿生殖器官基质移植的上皮转化
- 批准号:
16591631 - 财政年份:2004
- 资助金额:
$ 72.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
PROMOTING EFFECTS OF JUVENILE ESTROGEN TREATMENT ON DEVELOPMENT OF AUTOIMMUNE PROSTATITIS IN NEONATALLY THYMECTOMIZED MICE
幼年雌激素治疗对新生胸腺切除小鼠自身免疫性前列腺炎发展的促进作用
- 批准号:
13671684 - 财政年份:2001
- 资助金额:
$ 72.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Therapeutic strategy for hepatocellular carcinoma by dendritic cell-based tumor vaccination
基于树突状细胞的肿瘤疫苗接种治疗肝细胞癌的策略
- 批准号:
12557054 - 财政年份:2000
- 资助金额:
$ 72.13万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Therapetic strategy for chronic hepatitis C by inducing apoptosis of hepatocyte infected with hepatitis C virus
诱导丙型肝炎病毒感染肝细胞凋亡治疗慢性丙型肝炎的治疗策略
- 批准号:
11470132 - 财政年份:1999
- 资助金额:
$ 72.13万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Roles of heme in the regulation of gene expression and cell differentiation of erythroid cells
血红素在红系细胞基因表达和细胞分化调节中的作用
- 批准号:
10480163 - 财政年份:1998
- 资助金额:
$ 72.13万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Cytodifferentiation on cancer of urogenital tract organs via cell to cell interaction
通过细胞间相互作用进行泌尿生殖道器官癌症的细胞分化
- 批准号:
10671468 - 财政年份:1998
- 资助金额:
$ 72.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Gene manipulation of heme synthetic pathway enzymes
血红素合成途径酶的基因操作
- 批准号:
10557015 - 财政年份:1998
- 资助金额:
$ 72.13万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Therapeutic approach to hepatitis C by regulation of apoptosis-related gene
调控凋亡相关基因治疗丙型肝炎
- 批准号:
08457167 - 财政年份:1996
- 资助金额:
$ 72.13万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Regulation of erythroid differentiation by trnscription factors and heme
转录因子和血红素对红细胞分化的调节
- 批准号:
08458188 - 财政年份:1996
- 资助金额:
$ 72.13万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似海外基金
Impact of sarcopenia and creation of novel therapeutic targets by immunotherapeutic resistance mechanisms in hepatocellular carcinoma
肌少症的影响以及通过免疫治疗耐药机制创建新的治疗靶点对肝细胞癌的影响
- 批准号:
23K08106 - 财政年份:2023
- 资助金额:
$ 72.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of transcatheter arterial embolization for controlling hypoxia in hepatocellular carcinoma
经导管动脉栓塞控制肝细胞癌缺氧的研究进展
- 批准号:
23K07075 - 财政年份:2023
- 资助金额:
$ 72.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Dissecting the roles of iron and hemojuvelin in hepatocellular carcinoma
剖析铁和血幼素在肝细胞癌中的作用
- 批准号:
478251 - 财政年份:2023
- 资助金额:
$ 72.13万 - 项目类别:
Operating Grants
Determinants of immunotherapy response in NASH-Hepatocellular carcinoma
NASH-肝细胞癌免疫治疗反应的决定因素
- 批准号:
10735947 - 财政年份:2023
- 资助金额:
$ 72.13万 - 项目类别:
Targeting Ischemia-Induced Autophagy Dependence in hepatocellular Carcinoma through Image-guided Locoregional Therapy
通过图像引导局部治疗靶向肝细胞癌中缺血诱导的自噬依赖性
- 批准号:
10585078 - 财政年份:2023
- 资助金额:
$ 72.13万 - 项目类别:
Impact of TA-HEV expression on tumor microenvironment in hepatocellular carcinoma
TA-HEV表达对肝细胞癌肿瘤微环境的影响
- 批准号:
23K19513 - 财政年份:2023
- 资助金额:
$ 72.13万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Investigating the Metabolic Role of Vagal Insulin Signaling in Hepatocellular Carcinoma
研究迷走神经胰岛素信号在肝细胞癌中的代谢作用
- 批准号:
495140 - 财政年份:2023
- 资助金额:
$ 72.13万 - 项目类别:
Miscellaneous Programs
Center for therapeutic targeting of the Fusion Oncoprotein of Fibrolamellar Hepatocellular Carcinoma
纤维板层肝细胞癌融合癌蛋白治疗靶向中心
- 批准号:
10826323 - 财政年份:2023
- 资助金额:
$ 72.13万 - 项目类别:
Define the oncogenic role of Plk1 during hepatocellular carcinoma development using a genetically modified mouse model
使用转基因小鼠模型定义 Plk1 在肝细胞癌发展过程中的致癌作用
- 批准号:
10729603 - 财政年份:2023
- 资助金额:
$ 72.13万 - 项目类别:
An image-guided immunotherapy and hyperthermia delivery device to overcome barriers to tumor immunity for advanced hepatocellular carcinoma
一种图像引导免疫治疗和热疗装置,用于克服晚期肝细胞癌的肿瘤免疫障碍
- 批准号:
10585715 - 财政年份:2023
- 资助金额:
$ 72.13万 - 项目类别: